Elvina Jursenaite: Building Trust in Women’s Health

portrait photo Elvina Elvina Jursenaite

Elvina Juršėnaitė is the co founder and CEO of Misslaboratory, a med tech company focused on advancing hormone diagnostics in women’s health. With a background that spans e-commerce, yachting and now deep technology, her work sits at the intersection of science and business. She leads alongside a scientific co-founder Kotryna, translating complex research into clinically relevant tools designed for real world medical care.

Elvina Juršėnaitė approaches problems methodically. She listens, asks precise questions, and takes responsibility seriously. When she speaks about her work today, she focuses on how systems earn trust, from clinicians, from patients, and from institutions that rely on accurate data.

This way of thinking was shaped across very different environments. Fast paced digital commerce. The physical discipline and alertness of life at sea. And now the terrain of medical devices. Each environment demanded a different tempo, but all of them reinforced the same internal compass. Build responsibly. Understand the system you are entering. Take ownership of what your work puts into the world.

Health technology was not a casual pivot. It was a deliberate commitment to complexity. Medical devices operate at the intersection of science, regulation, and clinical responsibility.

She entered the field through a partnership built on trust and complementary strengths. A close friend, an experienced scientist, invited her to join the project and become a partner. What made the decision compelling was not only the scientific promise, but the possibility of building something meaningful together.

From the beginning, the collaboration was grounded in mutual respect. Deep scientific expertise met an execution driven entrepreneurial mindset. The goal was not simply to advance research, but to transform it into a usable medical solution that could stand up to clinical scrutiny.

One of the most formative challenges during this transition was stepping into a domain where she was not the expert. Working alongside highly specialized researchers required a recalibration of leadership.

In med tech, vision without discipline is meaningless. Impact without evidence is irresponsible. Elvina learned to hold ambition and restraint in balance, allowing science to move at its necessary pace while ensuring the work remained grounded in real world relevance.

There were several turning points along the way, but one stands out clearly. The decision to fully commit to building a med tech company rather than remaining in more conventional entrepreneurial spaces. It meant accepting a slower rhythm. One defined by validation, regulation, and long term accountability rather than quick iteration.

Another defining moment was the deepening of her partnership with a scientific co-founder. It transformed the work from an interesting project into a shared responsibility.

Engaging directly with clinicians further sharpened this sense of purpose. Listening to their frustrations. Seeing the limitations of current tools. Understanding how often medical decisions are made with incomplete or infrequent data, particularly in hormone related care.

In women’s health, these gaps are especially pronounced. Hormonal fluctuations are dynamic and individual, yet they are often reduced to averages or isolated snapshots. This realization reinforced the importance of the work ahead.

Today, Misslaboratory is focused on developing tools that enable more continuous and reliable hormone monitoring, designed to fit real clinical workflows.

Elvina explains.

This belief sits at the heart of Misslaboratory’s mission. Better data leads to better care. But only if that data is gathered responsibly, interpreted correctly, and integrated thoughtfully into clinical practice.

Elvina and her co-founder Kotryna lead side by side, with different roles but shared standards. Rigor. Trust. Respect for expertise. They are united by a sense of responsibility to the clinicians who will rely on these tools, and to the patients whose experiences are too often overlooked.

One of Elvina’s achievement is the confidence she has built over time to represent complex technology publicly. Speaking to clinicians, investors, and experts requires more than fluency. It requires accuracy. Integrity. The ability to translate without simplifying away what matters.

For her, success is defined by long-term impact, not short-term visibility.

Looking ahead, Elvina’s vision is clear. She wants to help turn complex science into tools that genuinely support clinical decisions. Through Misslaboratory, she aims to improve hormonal health monitoring in women’s health by enabling more timely and meaningful data.

Rather than claiming to disrupt healthcare, the work focuses on addressing specific gaps in existing hormone monitoring practices.

She draws inspiration not just from high profile role models, but from people she encounters along the way. Those who remain committed even when progress is slow or unseen.

At the center of Elvina Juršėnaitė’s story is a simple but demanding idea. That progress does not happen all at once. It is built through consistency. Through showing up. Through staying aligned with values even when shortcuts are tempting.

Misslaboratory is still evolving, as all meaningful work does. But it is being built with care, integrity, and a deep respect for the people it aims to serve.

The Real Edits

Every story has the power to shape how we see innovation, leadership, and purpose. If you’re a founder, creator, executive, or changemaker with a journey worth telling , we’d be honored to help you share it.

To inquire about being featured:
Email us at: info@realedit.site

Follow The Real Edit